J&J’s Janssen terminated its integrin research collaboration with Morphic Therapeutics. This follows the June 2022 termination of a partnership with AbbVie.
https://www.pharmalive.com/wp-content/uploads/2022/05/Janssen-Touts-Positive-Data-For-Tremfya-Stelara-BioSpace-5-25-22.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-01-23 11:06:422023-01-23 11:06:42Morphic loses another big pharma as J&J bails on research deal
